無料プレビュー

Edwards Lifesciences Corporation (EW) · New York Stock Exchange

プロフィール

Edwards Lifesciences is a global structural heart innovation company that designs, manufactures, and distributes minimally invasive and surgical therapies for patients with heart valve and structural heart diseases. The company's product portfolio spans transcatheter aortic valve replacement (TAVR), transcatheter mitral and tricuspid therapies (TMTT), and surgical structural heart devices, sold through direct sales forces and independent distributors. Edwards operates globally across the United States, Europe, Japan, and approximately one hundred other countries, with manufacturing facilities

主要指標

株価: $84.24 (-1.80%)
時価総額: 485億ドル
PER（今期予想）: 28.1
PBR: 4.6
配当利回り: —
52週レンジ: $72.30 – $96.29
業種: Healthcare / Medical - Devices
上場: New York Stock Exchange
構成銘柄: S&P 500 0.07%

比較会社: ABT Abbott Laboratories、ISRG Intuitive Surgical, Inc.、MDT Medtronic Plc、SYK Stryker Corporation、BSX Boston Scientific Corporation、DXCM DexCom, Inc.、GEHC GE HealthCare Technologies Inc.、PHG Koninklijke Philips N.V.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-11-04 · 更新: 2026-10-08